A Trial of HRS-9813 Capsule and Tablet in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 4, 2025

Primary Completion Date

June 3, 2025

Study Completion Date

June 23, 2025

Conditions

Pulmonary Fibrosis

Interventions

DRUG

HRS-9813 Capsule

HRS-9813 capsule.

DRUG

HRS-9813 Tablet

HRS-9813 tablet.

Trial Locations (1)

Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai

All Listed Sponsors

lead

Guangdong Hengrui Pharmaceutical Co., Ltd

INDUSTRY

NCT06939504 - A Trial of HRS-9813 Capsule and Tablet in Healthy Subjects | Biotech Hunter | Biotech Hunter